Literature DB >> 1430208

New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone.

P M Yen1, A Sugawara, S Refetoff, W W Chin.   

Abstract

Generalized resistance to thyroid hormone (GRTH) is a syndrome of hyposensitivity to triiodothyronine (T3) that displays autosomal dominant inheritance. The genetic defect commonly lies in the ligand-binding domain of one of the TR beta alleles. Since there are two major thyroid hormone receptor (TR) isoforms, TR alpha and TR beta, it is not known how the mutant receptor mediates a dominant negative effect. Previously, we showed that T3 caused dissociation of TR homodimers and TR alpha/TR beta dimers from several thyroid hormone response elements (TREs). Hence, we used the electrophoretic mobility shift assay to compare the effect of T3 on the DNA binding of mutant TR beta-1 (Mf-1) from a kindred with GRTH with normal TR beta. Mf-1 bound better as a homodimer than TR beta, but dissociated from DNA only at high T3 concentrations. Both receptors heterodimerized with nuclear auxiliary proteins. They also dimerized with TR alpha and with each other. Surprisingly, T3 disrupted the DNA binding of the Mf-1/TR isoform dimers. Thus, mechanisms for the dominant negative effect by mutant TRs likely involve either increased binding to TREs by mutant homodimers that cannot bind T3 (hence cannot dissociate from DNA) and/or the formation of inactive mutant TR/nuclear protein heterodimers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430208      PMCID: PMC443242          DOI: 10.1172/JCI116058

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Differential DNA binding by monomeric, homodimeric, and potentially heteromeric forms of the thyroid hormone receptor.

Authors:  M A Lazar; T J Berrodin; H P Harding
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

2.  Abnormalities of triiodothyronine binding to lymphocyte and fibroblast nuclei from a patient with peripheral tissue resistance to thyroid hormone action.

Authors:  J Bernal; S Refetoff; L J DeGroot
Journal:  J Clin Endocrinol Metab       Date:  1978-12       Impact factor: 5.958

3.  RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements.

Authors:  V C Yu; C Delsert; B Andersen; J M Holloway; O V Devary; A M Näär; S Y Kim; J M Boutin; C K Glass; M G Rosenfeld
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

4.  Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist.

Authors:  K Damm; C C Thompson; R M Evans
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

5.  Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors.

Authors:  V K Chatterjee; T Nagaya; L D Madison; S Datta; A Rentoumis; J L Jameson
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

6.  A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.

Authors:  S J Usala; G E Tennyson; A E Bale; R W Lash; N Gesundheit; F E Wondisford; D Accili; P Hauser; B D Weintraub
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

7.  3,5,3'-triiodothyronine receptor auxiliary protein (TRAP) enhances receptor binding by interactions within the thyroid hormone response element.

Authors:  J S Beebe; D S Darling; W W Chin
Journal:  Mol Endocrinol       Date:  1991-01

8.  A new point mutation in the 3,5,3'-triiodothyronine-binding domain of the c-erbA beta thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance.

Authors:  S J Usala; J B Menke; T L Watson; W E Bérard; C Bradley; A E Bale; R W Lash; B D Weintraub
Journal:  J Clin Endocrinol Metab       Date:  1991-01       Impact factor: 5.958

9.  Isoform-specific thyroid hormone receptor antibodies detect multiple thyroid hormone receptors in rat and human pituitaries.

Authors:  P M Yen; M E Sunday; D S Darling; W W Chin
Journal:  Endocrinology       Date:  1992-03       Impact factor: 4.736

10.  Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors.

Authors:  K Umesono; K K Murakami; C C Thompson; R M Evans
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

View more
  17 in total

1.  Autoimmunity in patients with resistance to thyroid hormone.

Authors:  Marla S Barkoff; Masha Kocherginsky; João Anselmo; Roy E Weiss; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

Review 2.  Homozygous thyroid hormone receptor β-gene mutations in resistance to thyroid hormone: three new cases and review of the literature.

Authors:  Alfonso Massimiliano Ferrara; Kazumichi Onigata; Oya Ercan; Helen Woodhead; Roy E Weiss; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

3.  Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1).

Authors:  Laura Fozzatti; Changxue Lu; Dong Wook Kim; Jeong Won Park; Inna Astapova; Oksana Gavrilova; Mark C Willingham; Anthony N Hollenberg; Sheue-yann Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

Review 4.  Transcription factors in inner ear development.

Authors:  D P Corey; X O Breakefield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

5.  Alpha and beta thyroid hormone receptor (TR) gene expression during auditory neurogenesis: evidence for TR isoform-specific transcriptional regulation in vivo.

Authors:  D J Bradley; H C Towle; W S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

6.  Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.

Authors:  C A Meier; C Parkison; A Chen; K Ashizawa; S C Meier-Heusler; P Muchmore; S Y Cheng; B D Weintraub
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 7.  Germline and somatic thyroid hormone receptor mutations in man.

Authors:  P M Yen; S Y Cheng
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

8.  Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.

Authors:  R Wong; X G Zhu; M A Pineda; S Y Cheng; B D Weintraub
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

9.  Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.

Authors:  Y Hayashi; T Sunthornthepvarakul; S Refetoff
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

10.  Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene.

Authors:  M Adams; C Matthews; T N Collingwood; Y Tone; P Beck-Peccoz; K K Chatterjee
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.